Eli Lilly Dividends and Buybacks

Dividend criteria checks 0/6

Eli Lilly is a dividend paying company with a current yield of 0.78%. Next payment date is on 10th March, 2025 with an ex-dividend date of 14th February, 2025.

Key information

0.8%

Dividend yield

0.06%

Buyback Yield

Total Shareholder Yield0.8%
Future Dividend Yield0.9%
Dividend Growth-12.0%
Next dividend pay date10 Mar 25
Ex dividend date14 Feb 25
Dividend per share€6.000
Payout ratio54%

Recent dividend and buyback updates

Recent updates

Upcoming Dividend Payment

TodayDec 22 2024Ex Dividend DateFeb 14 2025Dividend Pay DateMar 10 202524 days from Ex DividendBuy in the next 53 days to receive the upcoming dividend

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: LLYC is not paying a notable dividend for the Austrian market, therefore no need to check if payments are stable.

Growing Dividend: LLYC is not paying a notable dividend for the Austrian market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

Eli Lilly Dividend Yield vs Market
How does LLYC dividend yield compare to the market?
SegmentDividend Yield
Company (LLYC)0.8%
Market Bottom 25% (AT)2.3%
Market Top 25% (AT)6.2%
Industry Average (Pharmaceuticals)2.7%
Analyst forecast (LLYC) (up to 3 years)0.9%

Notable Dividend: LLYC's dividend (0.78%) isn’t notable compared to the bottom 25% of dividend payers in the Austrian market (2.28%).

High Dividend: LLYC's dividend (0.78%) is low compared to the top 25% of dividend payers in the Austrian market (6.21%).


Earnings Payout to Shareholders

Earnings Coverage: LLYC is not paying a notable dividend for the Austrian market.


Cash Payout to Shareholders

Cash Flow Coverage: LLYC is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 21:22
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eli Lilly and Company is covered by 63 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Alistair CampbellBerenberg